Jerald J. Killion

3.8k total citations
68 papers, 3.1k citations indexed

About

Jerald J. Killion is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jerald J. Killion has authored 68 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 23 papers in Immunology and 21 papers in Oncology. Recurrent topics in Jerald J. Killion's work include Cancer Research and Treatments (12 papers), Immunotherapy and Immune Responses (11 papers) and Angiogenesis and VEGF in Cancer (9 papers). Jerald J. Killion is often cited by papers focused on Cancer Research and Treatments (12 papers), Immunotherapy and Immune Responses (11 papers) and Angiogenesis and VEGF in Cancer (9 papers). Jerald J. Killion collaborates with scholars based in United States, Australia and Switzerland. Jerald J. Killion's co-authors include Isaiah J. Fidler, Isaiah J. Fidler, Robert Radinsky, Colin P. Dinney, Corazon D. Bucana, I. J. Fidler, Sen Pathak, Dominic Fan, Simon Tanguay and Hisanori Uehara and has published in prestigious journals such as Nature, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Jerald J. Killion

68 papers receiving 3.0k citations

Peers

Jerald J. Killion
Vincent L. Morris Canada
Richard C. Bates United States
C Bucana United States
Brigitte Mack Germany
Walter E. Laug United States
Nicole Meyer-Morse United States
William E. Fogler United States
Mahvash Tavassoli United Kingdom
Neil I. Goldstein United States
Maria G. Pallavicini United States
Vincent L. Morris Canada
Jerald J. Killion
Citations per year, relative to Jerald J. Killion Jerald J. Killion (= 1×) peers Vincent L. Morris

Countries citing papers authored by Jerald J. Killion

Since Specialization
Citations

This map shows the geographic impact of Jerald J. Killion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerald J. Killion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerald J. Killion more than expected).

Fields of papers citing papers by Jerald J. Killion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerald J. Killion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerald J. Killion. The network helps show where Jerald J. Killion may publish in the future.

Co-authorship network of co-authors of Jerald J. Killion

This figure shows the co-authorship network connecting the top 25 collaborators of Jerald J. Killion. A scholar is included among the top collaborators of Jerald J. Killion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerald J. Killion. Jerald J. Killion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Apte, Sachin M., Corazon D. Bucana, Jerald J. Killion, David M. Gershenson, & Isaiah J. Fidler. (2004). Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines. Gynecologic Oncology. 93(1). 78–86. 69 indexed citations
2.
Myers, Jeffrey N., F. Christopher Holsinger, B. Nebiyou Bekele, et al.. (2002). Targeted Molecular Therapy for Oral Cancer With Epidermal Growth Factor Receptor Blockade. Archives of Otolaryngology - Head and Neck Surgery. 128(8). 875–875. 22 indexed citations
3.
Solórzano, Carmen C., Cheryl H. Baker, Christiane J. Bruns, et al.. (2001). Inhibition of Growth and Metastasis of Human Pancreatic Cancer Growing in Nude Mice by PTK 787/ZK222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases. Cancer Biotherapy and Radiopharmaceuticals. 16(5). 359–370. 103 indexed citations
4.
Shinohara, Hisashi, C Bucana, Jerald J. Killion, & Isaiah J. Fidler. (2000). Intensified Regression of Colon Cancer Liver Metastases in Mice Treated with Irinotecan and the Immunomodulator JBT 3002. Journal of Immunotherapy. 23(3). 321–331. 13 indexed citations
5.
Kumar, Rakesh, Keping Xie, Ines Eue, et al.. (2000). Differential regulation of type IV collagenases and metalloelastase in murine macrophages by the synthetic bacterial lipopeptide JBT 3002. International Journal of Immunopharmacology. 22(6). 431–443. 6 indexed citations
6.
Yoneda, Junya, Jerald J. Killion, Corazon D. Bucana, & Isaiah J. Fidler. (1999). Angiogenesis and Growth of Murine Colon Carcinoma are Dependent on Infiltrating Leukocytes. Cancer Biotherapy and Radiopharmaceuticals. 14(3). 221–230. 4 indexed citations
7.
Killion, Jerald J.. (1998). Therapy of Cancer Metastasis by Tumoricidal Activation of Tissue Macrophages Using Liposome-Encapsulated Immunomodulators. Pharmacology & Therapeutics. 78(3). 141–154. 43 indexed citations
8.
Killion, Jerald J., Robert Radinsky, & Isaiah J. Fidler. (1998). Orthotopic Models are Necessary to Predict Therapy of Transplantable Tumors in Mice. Cancer and Metastasis Reviews. 17(3). 279–284. 340 indexed citations
9.
Balasubramanian, Krishnakumar, Jerald J. Killion, & Alan J. Schroit. (1998). Estimation of Plasma Beta-2-Glycoprotein Levels by Competitive ELISA. Thrombosis Research. 92(2). 91–97. 5 indexed citations
10.
Kumar, Rakesh, Ines Eue, Zhongyun Dong, Jerald J. Killion, & Isaiah J. Fidler. (1997). Expression of Inflammatory Cytokines by Murine Macrophages Activated with a New Synthetic Lipopeptide JT3002. Cancer Biotherapy and Radiopharmaceuticals. 12(5). 333–340. 7 indexed citations
11.
Killion, Jerald J. & Isaiah J. Fidler. (1994). Systemic Targeting of Liposome-Encapsulated Immunomodulators to Macrophages for Treatment of Cancer Metastasis. PubMed. 4(3). 273–279. 17 indexed citations
12.
13.
Stephenson, Robert A., Colin P. Dinney, Kazuo Gohji, et al.. (1992). Metastatic Model for Human Prostate Cancer Using Orthotopic Implantation in Nude Mice. JNCI Journal of the National Cancer Institute. 84(12). 951–957. 259 indexed citations
14.
Killion, Jerald J., et al.. (1990). Isolation of Human Colon Carcinoma Cells for Resistance to a Single Interferon Associated With Cross-Resistance to Multiple Recombinant Interferons:  , beta, and  . JNCI Journal of the National Cancer Institute. 82(6). 517–522. 14 indexed citations
15.
16.
Killion, Jerald J., et al.. (1989). Augmentation of Antiproliferative Activity of Interferon Alfa Against Human Bladder Tumor Cell Lines by Encapsulation of Interferon Alfa Within Liposomes. JNCI Journal of the National Cancer Institute. 81(18). 1387–1392. 24 indexed citations
17.
Dunn, Jon D. & Jerald J. Killion. (1988). Effect of melittin on pituitary-adrenal responsiveness to stress. European Journal of Endocrinology. 119(3). 339–344. 2 indexed citations
18.
Dunn, Jon D. & Jerald J. Killion. (1988). Melittin-evoked increase in plasma corticosterone levels. Life Sciences. 43(4). 335–343. 8 indexed citations
19.
Cantrell, John L., Jerald J. Killion, & Gwendlyn Kollmorgen. (1976). Correlations between humoral immunity and successful chemotherapy-immunotherapy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(9 pt.1). 3051–7. 15 indexed citations
20.
Killion, Jerald J., et al.. (1973). Some physical parameters affecting the agglutination of l-5178y leuke- mic cells with concanavalin a. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 113–114. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent L. Morris Breakdown of academic impact, for papers by Richard C. Bates Breakdown of academic impact, for papers by C Bucana Breakdown of academic impact, for papers by Brigitte Mack Breakdown of academic impact, for papers by Walter E. Laug Breakdown of academic impact, for papers by Nicole Meyer-Morse Breakdown of academic impact, for papers by William E. Fogler Breakdown of academic impact, for papers by Mahvash Tavassoli Breakdown of academic impact, for papers by Neil I. Goldstein Breakdown of academic impact, for papers by Maria G. Pallavicini
Rankless by CCL
2026